Deborah Quail

1.5k total citations
44 papers, 1.2k citations indexed

About

Deborah Quail is a scholar working on Pharmacology, Psychiatry and Mental health and Rheumatology. According to data from OpenAlex, Deborah Quail has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 14 papers in Psychiatry and Mental health and 9 papers in Rheumatology. Recurrent topics in Deborah Quail's work include Treatment of Major Depression (18 papers), Pelvic floor disorders treatments (9 papers) and Estrogen and related hormone effects (8 papers). Deborah Quail is often cited by papers focused on Treatment of Major Depression (18 papers), Pelvic floor disorders treatments (9 papers) and Estrogen and related hormone effects (8 papers). Deborah Quail collaborates with scholars based in United Kingdom, Germany and Spain. Deborah Quail's co-authors include Brigitta U. Monz, David Pérahia, Ángel L. Montejo, Adrian Wagg, Koen Demyttenaere, André Tylee, Christian Hampel, Luigi Grassi, Catherine Reed and N. Dantchev and has published in prestigious journals such as Neurology, American Journal of Obstetrics and Gynecology and European Urology.

In The Last Decade

Deborah Quail

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah Quail United Kingdom	20	359	287	265	222	173	44	1.2k
Sean Martin Australia	29	184 0.5×	156 0.5×	186 0.7×	186 0.8×	311 1.8×	73	2.2k
Ulla Rajala Finland	24	125 0.3×	30 0.1×	125 0.5×	358 1.6×	91 0.5×	66	1.7k
Walter Deberdt United States	25	214 0.6×	145 0.5×	1.1k 4.1×	157 0.7×	92 0.5×	62	1.8k
Martin Burkart Germany	18	59 0.2×	133 0.5×	302 1.1×	99 0.4×	43 0.2×	48	860
Andrew Greenspan United States	24	226 0.6×	200 0.7×	867 3.3×	67 0.3×	40 0.2×	41	1.8k
Mugdha Gore United States	18	1.1k 3.1×	158 0.6×	337 1.3×	102 0.5×	90 0.5×	29	2.2k
Joshua Liberman United States	14	102 0.3×	142 0.5×	1.4k 5.1×	151 0.7×	52 0.3×	17	2.2k
Ann Taylor United Kingdom	17	662 1.8×	75 0.3×	923 3.5×	87 0.4×	29 0.2×	28	1.8k
Eylem Şahin Cankurtaran Türkiye	21	60 0.2×	58 0.2×	275 1.0×	79 0.4×	43 0.2×	40	1.1k
Sujata Thakurta United States	14	284 0.8×	63 0.2×	373 1.4×	48 0.2×	27 0.2×	70	936

Countries citing papers authored by Deborah Quail

Since Specialization

Citations

This map shows the geographic impact of Deborah Quail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Quail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Quail more than expected).

Fields of papers citing papers by Deborah Quail

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Quail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Quail. The network helps show where Deborah Quail may publish in the future.

Co-authorship network of co-authors of Deborah Quail

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Quail. A scholar is included among the top collaborators of Deborah Quail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Quail. Deborah Quail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Romera, Irene, Víctor Pérez, Deborah Quail, et al.. (2014). Individual residual symptoms and functional impairment in patients with depression. Psychiatry Research. 220(1-2). 258–262. 19 indexed citations

Cardo, Esther, Vibeke Porsdal, Deborah Quail, et al.. (2013). Fast vs. Slow Switching from Stimulants to Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 23(4). 252–261. 3 indexed citations

Fuentes, Joaquín, Marina Danckaerts, Esther Cardo, et al.. (2013). Long-Term Quality-of-Life and Functioning Comparison of Atomoxetine Versus Other Standard Treatment in Pediatric Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology. 33(6). 766–774. 16 indexed citations

Montoya, Alonso, Deborah Quail, Ernie Anand, et al.. (2013). Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis. ADHD Attention Deficit and Hyperactivity Disorders. 6(1). 25–34. 2 indexed citations

Hegerl, Ulrich, Roland Mergl, Deborah Quail, et al.. (2012). Fast versus slow onset of depressive episodes: A clinical criterion for subtyping patients with major depression. European Psychiatry. 28(5). 288–292. 5 indexed citations

Dantchev, N., et al.. (2012). Résultats de la cohorte française de l’étude observationnelle européenne FINDER : qualité de vie de patients traités par antidépresseurs. L Encéphale. 39(2). 101–108.

Demyttenaere, Koen, Catherine Reed, Deborah Quail, et al.. (2010). Presence and predictors of pain in depression: Results from the FINDER study. Journal of Affective Disorders. 125(1-3). 53–60. 36 indexed citations

Manning, Michael R., et al.. (2009). How are women with SUI-symptoms treated with duloxetine in real life practice? - Preliminary results from a large observational study in Germany. International Journal of Clinical Practice. 63(12). 1724–1733. 3 indexed citations

Falconer, Christian, et al.. (2009). Patient reported outcomes tools in an observational study of female stress urinary incontinence. Neurourology and Urodynamics. 29(3). 348–353. 12 indexed citations

10.

Bauer, Michael, Brigitta U. Monz, Ángel L. Montejo, et al.. (2008). Prescribing patterns of antidepressants in Europe: Results from the Factors Influencing Depression Endpoints Research (FINDER) study. European Psychiatry. 23(1). 66–73. 149 indexed citations

11.

Pérahia, David, Deborah Quail, D. Desaiah, Ángel L. Montejo, & Alan F. Schatzberg. (2008). Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: Effects on painful physical symptoms of depression. Journal of Psychiatric Research. 43(5). 512–518. 46 indexed citations

12.

Garcia-Cebrian, A, Michael Bauer, Ángel L. Montejo, et al.. (2007). Factors influencing depression endpoints research (FINDER): Study design and population characteristics. European Psychiatry. 23(1). 57–65. 20 indexed citations

13.

Pérahia, David, et al.. (2007). A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression. Journal of Affective Disorders. 108(1-2). 33–41. 11 indexed citations

14.

Hornyak, Magdolna, Hans‐Peter Hundemer, Deborah Quail, et al.. (2007). Relationship of periodic leg movements and severity of restless legs syndrome: A study in unmedicated and medicated patients. Clinical Neurophysiology. 118(7). 1532–1537. 16 indexed citations

15.

Neven, Patrick, Deborah Quail, Fernando Marín, et al.. (2005). Comparing raloxifene with continuous combined estrogen–progestin therapy in postmenopausal women: Review of Euralox 1. Maturitas. 52(2). 87–101. 12 indexed citations

16.

Neven, Patrick, Deborah Quail, Christian De Geyter, et al.. (2004). Uterine Effects of Estrogen Plus Progestin Therapy and Raloxifene: Adjudicated Results From the EURALOX Study. Obstetrics and Gynecology. 103(5, Part 1). 881–891. 9 indexed citations

17.

Palacios, Santiago, Maria Lúcia Fleiuss Farias, Gustavo Gómez, et al.. (2004). Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate. American Journal of Obstetrics and Gynecology. 191(1). 121–131. 17 indexed citations

18.

Voss, Simon, Deborah Quail, Mithat Erenus, et al.. (2002). A randomised, double‐blind trial comparing raloxifene HCl and continuous combined hormone replacement therapy in postmenopausal women: effects on compliance and quality of life. BJOG An International Journal of Obstetrics & Gynaecology. 109(8). 874–885. 21 indexed citations

19.

Judge, R., M G Parry, Deborah Quail, & Jennie G. Jacobson. (2002). Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. International Clinical Psychopharmacology. 17(5). 217–225. 71 indexed citations

20.

Trafford, J. A. P., et al.. (1989). A multi-centre, placebo controlled comparative study between 200 mg and 400 mg celiprolol in patients with mild to moderate essential hypertension. Current Medical Research and Opinion. 11(9). 550–556. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact